RPRX 8-K 2026-08-05

Royalty Pharma plc (RPRX) 8-K dated 2026-08-05 — accession 0001802768-26-000014. This URL is the filing, not the RPRX hub.

Royalty Pharma plc (RPRX) is a biotechnology company listed on US.

Royalty Pharma plc filed a 8-K on 2026-08-05. Accession 0001802768-26-000014.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RPRX revenue for 2026-06-30 was $1.30B. Net income was $312.6M. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.

Not investment advice. The RPRX SEC hub lists recent forms. The stock page is the research view.